Story
Attovia Therapeutics Raises $332.4 Million in Nasdaq IPO

Clinical-stage biopharmaceutical company Attovia Therapeutics (Nasdaq: ATTO) has successfully closed its initial public offering, raising approximately $332.4 million in gross proceeds before underwriting discounts and other expenses. The company's shares began trading on the Nasdaq Global Market on August 5, 2026.
Offering Details
The San Carlos, California-based company sold a total of 19,550,000 shares at a public offering price of $17.00 per share. According to the announcement, all shares were offered by Attovia.
The final share count includes the full exercise of the underwriters’ option to purchase an additional 2,550,000 shares, which contributed to the total proceeds raised. The offering officially closed on August 6, 2026.
Market Debut and Underwriters
The U.S. Securities and Exchange Commission (SEC) declared the registration statement for the offering effective on August 4, 2026, paving the way for the market debut. A consortium of investment banks managed the transaction.
AdMorgan Stanley, Leerink Partners, Citigroup, and RBC Capital Markets acted as joint book-running managers for the offering. LifeSci Capital served as a passive book-running manager.
Company Pipeline
Attovia Therapeutics focuses on developing novel treatments for inflammatory and immune-mediated diseases. The capital raised from the IPO is expected to help advance its development pipeline, which includes:
- ATTO-1310: An anti-IL-31 therapeutic currently in clinical development for chronic pruritic diseases.
- ATTO-2306: A bispecific antibody targeting IL-31 and IL-13 for atopic dermatitis, which is in IND-enabling studies.
- ATTO-1091: A trispecific antibody for inflammatory bowel disease, also in IND-enabling studies.
Read next
More on Stocks
FTC Orders Walmart, Uber, Delta to Disclose Data on Personalized Pricing
The U.S. Federal Trade Commission is demanding nine major companies, including leading retail, travel, and gig economy firms, to provide information on how they use consumer data for setting individual prices and wages.

Google Launches Gemini 4 Carbon AI Model to Bolster Cybersecurity Capabilities
Alphabet's Google has unveiled Gemini 4 Carbon, its latest AI model specifically designed for advanced cybersecurity tasks like vulnerability detection and secure code generation. The launch escalates competition with rivals OpenAI and Anthropic in the enterprise AI market.

Oracle Shares Surge After Unveiling $225 Billion Revenue Target for 2030
Oracle stock rose sharply after the company presented a long-term financial outlook targeting at least $225 billion in annual revenue by fiscal 2030, driven by its expanding AI infrastructure business.

DOJ Scrutinizes Nvidia's $12.9B Hugging Face Deal Amid Broader Antitrust Probe, Sources Say
The U.S. Department of Justice is reportedly examining Nvidia's planned $12.93 billion acquisition of AI platform Hugging Face as part of a wider, ongoing antitrust investigation into the chipmaker's market conduct.